Aperio Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $5.13M | Buy |
118,318
+66,669
| +129% | +$2.89M | 0.02% | 823 |
|
2020
Q3 | $1.81M | Buy |
51,649
+7,388
| +17% | +$259K | 0.01% | 1163 |
|
2020
Q2 | $2.37M | Buy |
44,261
+10,077
| +29% | +$539K | 0.01% | 1031 |
|
2020
Q1 | $1.21M | Sell |
34,184
-7,209
| -17% | -$256K | 0.01% | 1228 |
|
2019
Q4 | $1.98M | Buy |
41,393
+19,111
| +86% | +$913K | 0.01% | 1094 |
|
2019
Q3 | $722K | Buy |
22,282
+4,731
| +27% | +$153K | ﹤0.01% | 1566 |
|
2019
Q2 | $875K | Buy |
17,551
+9,705
| +124% | +$484K | ﹤0.01% | 1466 |
|
2019
Q1 | $529K | Buy |
7,846
+1,769
| +29% | +$119K | ﹤0.01% | 1725 |
|
2018
Q4 | $280K | Buy |
6,077
+2,283
| +60% | +$105K | ﹤0.01% | 1973 |
|
2018
Q3 | $293K | Sell |
3,794
-94
| -2% | -$7.26K | ﹤0.01% | 2022 |
|
2018
Q2 | $327K | Buy |
3,888
+81
| +2% | +$6.81K | ﹤0.01% | 1959 |
|
2018
Q1 | $311K | Buy |
+3,807
| New | +$311K | ﹤0.01% | 1940 |
|
2017
Q4 | – | Sell |
-4,074
| Closed | -$272K | – | 2239 |
|
2017
Q3 | $272K | Buy |
4,074
+72
| +2% | +$4.81K | ﹤0.01% | 1969 |
|
2017
Q2 | $206K | Buy |
+4,002
| New | +$206K | ﹤0.01% | 2083 |
|
2016
Q3 | – | Sell |
-5,572
| Closed | -$233K | – | 2063 |
|
2016
Q2 | $233K | Buy |
5,572
+320
| +6% | +$13.4K | ﹤0.01% | 1781 |
|
2016
Q1 | $213K | Buy |
+5,252
| New | +$213K | ﹤0.01% | 1841 |
|